Evidence map›Paper›PMID 28459997›Full record

ArticleBrain : a journal of neurology2017

Hypomorphic mutations in POLR3A are a frequent cause of sporadic and recessive spastic ataxia.

Martina Minnerop, Delia Kurzwelly, Holger Wagner, Anne S Soehn, Jennifer Reichbauer, Feifei Tao, Tim W Rattay, Michael Peitz, Kristina Rehbach, Alejandro Giorgetti and 46 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 119 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in genetics · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Two Novel Variants inNeurology. Genetics · 2024
    Article
  18. Article
  19. Article
  20. Neuroradiological findings in GAA-medRxiv : the preprint server for health sciences · 2024
    Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

56 authors at 20 institutions in 9 countries.

Martina MinneropInstitute of Neuroscience and Medicine (INM-1), Research Centre Juelich, 52425 Jülich, Germany.
Delia KurzwellyDepartment of Neurology, University of Bonn, 53127 Bonn, Germany.
Holger WagnerDepartment of Psychiatry and Psychotherapy, University of Bonn, 53127 Bonn, Germany.
Anne S SoehnInstitute of Medical Genetics and Applied Genomics, University of Tübingen, 72076 Tübingen, Germany.
Jennifer ReichbauerCenter for Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany.
Feifei TaoDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.
Tim W RattayCenter for Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany.
Michael PeitzGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Kristina RehbachGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Alejandro GiorgettiComputational Biophysics, German Research School for Simulation Sciences, and Computational Biomedicine, Institute for Advanced Simulation (IAS-5) and Institute of Neuroscience and Medicine (INM-9), Research Centre Juelich, 52425 Jülich, Germany.
Angela PyleInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK.
Holger ThieleCologne Center for Genomics (CCG), University of Cologne, 50931 Cologne, Germany.
Janine AltmüllerCologne Center for Genomics (CCG), University of Cologne, 50931 Cologne, Germany.
Dagmar TimmannDepartment of Neurology, University of Duisburg-Essen, 45147 Essen, Germany.
Ilker KaracaDepartment of Psychiatry and Psychotherapy, University of Bonn, 53127 Bonn, Germany.
Martina LennarzDepartment of Psychiatry and Psychotherapy, University of Bonn, 53127 Bonn, Germany.
Jonathan BaetsNeurogenetics Group, VIB-Department of Molecular Genetics, VIB, 2610 Antwerp, Belgium.
Holger HengelCenter for Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany.
Matthis SynofzikCenter for Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany.
Burcu AtasuGerman Center for Neurodegenerative Diseases (DZNE), 72076 Tübingen, Germany.
Shawna FeelyDepartment of Neurology, University of Iowa, 52242 Iowa, USA.
Marina KennersonNorthcott Neuroscience Laboratory, ANZAC Research Institute, Concord NSW 2139, Australia.
Claudia StendelDepartment of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-Universität, 80336 Munich, Germany.
Tobias LindigDepartment of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, 72076 Tübingen, Germany.
Michael A GonzalezDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.
Rüdiger StirnbergGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Marc SturmInstitute of Medical Genetics and Applied Genomics, University of Tübingen, 72076 Tübingen, Germany.
Sandra RoeskeGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Johanna JungGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Peter BauerInstitute of Medical Genetics and Applied Genomics, University of Tübingen, 72076 Tübingen, Germany.
Ebba LohmannGerman Center for Neurodegenerative Diseases (DZNE), 72076 Tübingen, Germany.
Stefan HermsInstitute of Human Genetics, University of Bonn, 53127 Bonn, Germany.
Stefanie Heilmann-HeimbachInstitute of Human Genetics, University of Bonn, 53127 Bonn, Germany.
Garth NicholsonNorthcott Neuroscience Laboratory, ANZAC Research Institute, Concord NSW 2139, Australia.
Muhammad MahanjahChild Neurology and Development Center, Hillel-Yaffe Medical Center, 38100 Hadera, Israel.
Rajech SharkiaThe Triangle Regional Research and Development Center, P. O. Box-2167, Kfar Qari' 30075, Israel.
Paolo CarloniComputational Biophysics, German Research School for Simulation Sciences, and Computational Biomedicine, Institute for Advanced Simulation (IAS-5) and Institute of Neuroscience and Medicine (INM-9), Research Centre Juelich, 52425 Jülich, Germany.
Oliver BrüstleGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Thomas KlopstockDepartment of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-Universität, 80336 Munich, Germany.
Katherine D MathewsDepartment of Pediatrics, Carver College of Medicine, University of Iowa, 52242 Iowa, USA.
Michael E ShyDepartment of Neurology, University of Iowa, 52242 Iowa, USA.
Peter de JongheNeurogenetics Group, VIB-Department of Molecular Genetics, VIB, 2610 Antwerp, Belgium.
Patrick F ChinneryInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK.
Rita HorvathWellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK.
Jürgen KohlhaseCenter for Human Genetics Freiburg, 79100 Freiburg, Germany.
Ina SchmittDepartment of Neurology, University of Bonn, 53127 Bonn, Germany.
Michael WolfDepartement of Orthodontics, University of Bonn, 53111 Bonn, Germany.
Susanne GreschusDepartment of Radiology, University of Bonn, 53127 Bonn, Germany.
Katrin AmuntsInstitute of Neuroscience and Medicine (INM-1), Research Centre Juelich, 52425 Jülich, Germany.
Wolfgang MaierGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Ludger SchölsCenter for Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany.
Peter NürnbergInstitute of Neuroscience and Medicine (INM-1), Research Centre Juelich, 52425 Jülich, Germany.
Stephan ZuchnerDr. John T. Macdonald Foundation Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.
Thomas KlockgetherDepartment of Neurology, University of Bonn, 53127 Bonn, Germany.
Alfredo RamirezDepartment of Psychiatry and Psychotherapy, University of Bonn, 53127 Bonn, Germany.
Rebecca SchüleCenter for Neurology and Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany.
German Center for Neurodegenerative Diseases · DEUniversity of Bonn · DEUniversity of Tübingen · DELife & Brain (Germany) · DEUniversity of Iowa · USAnzac Research Institute · AUHertie Institute for Clinical Brain Research · DENewcastle University · GBUniversity of Cologne · DEUniversity of Miami · USAntwerp University Hospital · BEBeit Berl College · ILCologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases · DEDr. John T. Macdonald Foundation · USForschungszentrum Jülich · DEFriedrich Baur Stiftung · DEGerman Research School for Simulation Sciences · DEHillel Yaffe Medical Center · ILLudwig-Maximilians-Universität München · DEUniversity Hospital Cologne · DE

Funding

trainingU54NS065712 · NINDS · WAYNE STATE UNIVERSITY · PI SHY, MICHAEL E. · 2009 to 2023
$19.6M
GENOME STUDIES IN HEREDITARY SPASTIC PARAPLEGIA - beyond the exomeR01NS072248 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Stephan Zuchner · 2011 to 2026
$9.2M
Genomic Studies in Charcot-Marie-Tooth DiseaseR01NS075764 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SHY, MICHAEL E., ZUCHNER, STEPHAN · 2012 to 2016
$3.0M
Medical Research Council MC_UP_1501/2Medical Research Council MR/N025431/1NINDS NIH HHS R01 NS072248NINDS NIH HHS R01 NS075764NINDS NIH HHS U54 NS065712
6 · The paper itself

Abstract

Despite extensive efforts, half of patients with rare movement disorders such as hereditary spastic paraplegias and cerebellar ataxias remain genetically unexplained, implicating novel genes and unrecognized mutations in known genes. Non-coding DNA variants are suspected to account for a substantial part of undiscovered causes of rare diseases. Here we identified mutations located deep in introns of POLR3A to be a frequent cause of hereditary spastic paraplegia and cerebellar ataxia. First, whole-exome sequencing findings in a recessive spastic ataxia family turned our attention to intronic variants in POLR3A, a gene previously associated with hypomyelinating leukodystrophy type 7. Next, we screened a cohort of hereditary spastic paraplegia and cerebellar ataxia cases (n = 618) for mutations in POLR3A and identified compound heterozygous POLR3A mutations in ∼3.1% of index cases. Interestingly, >80% of POLR3A mutation carriers presented the same deep-intronic mutation (c.1909+22G>A), which activates a cryptic splice site in a tissue and stage of development-specific manner and leads to a novel distinct and uniform phenotype. The phenotype is characterized by adolescent-onset progressive spastic ataxia with frequent occurrence of tremor, involvement of the central sensory tracts and dental problems (hypodontia, early onset of severe and aggressive periodontal disease). Instead of the typical hypomyelination magnetic resonance imaging pattern associated with classical POLR3A mutations, cases carrying c.1909+22G>A demonstrated hyperintensities along the superior cerebellar peduncles. These hyperintensities may represent the structural correlate to the cerebellar symptoms observed in these patients. The associated c.1909+22G>A variant was significantly enriched in 1139 cases with spastic ataxia-related phenotypes as compared to unrelated neurological and non-neurological phenotypes and healthy controls (P = 1.3 × 10-4). In this study we demonstrate that (i) autosomal-recessive mutations in POLR3A are a frequent cause of hereditary spastic ataxias, accounting for about 3% of hitherto genetically unclassified autosomal recessive and sporadic cases; and (ii) hypomyelination is frequently absent in POLR3A-related syndromes, especially when intronic mutations are present, and thus can no longer be considered as the unifying feature of POLR3A disease. Furthermore, our results demonstrate that substantial progress in revealing the causes of Mendelian diseases can be made by exploring the non-coding sequences of the human genome.

Indexed as

AgedCell Culture TechniquesExonsFemaleGenetic Association StudiesHumansInduced Pluripotent Stem CellsIntellectual DisabilityIntronsMaleMiddle AgedMuscle SpasticityMutationOptic AtrophyPedigreePhenotypePOLR3A protein, humanRNA Polymerase IIIcerebellar ataxiahereditary spastic paraplegialeukodystrophyPOLR3Aspastic ataxia

Identifiers

PMID28459997
PMCPMC6402316
OpenAlexW2608549585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.